ARESP IVS: Financial statements 2020
CVR: 38362720
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
ARESP IVS (CVR 38362720) has filed annual accounts for 2020. In 2020, the company reported a net result of DKK 0 compared with DKK 30 the year before. Equity in the 2020 report amounted to DKK 4,000. The solvency ratio was 39.3%.
- Profit/Loss
- DKK 0
- Equity
- DKK 4,000
- Total Assets
- DKK 10,177
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | - | 0 | 4 t. | - |
| 2019 | 0 | 30 | 30 | 3 t. | - |
| 2018 | 0 | -968 | -598 | 3 t. | - |
| 2017 | 0 | -670 | -670 | 3 t. | - |
Official annual report
How creditworthy is ARESP IVS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
ARESP IVS has published its annual report for 2019. Revenue came to DKK 0, and the net result was DKK 30.
About ARESP IVS
ARESP IVS was a Danish company of the type Iværksætterselskab based in Tranbjerg J, founded in 2017. The company has been dissolved on 14 October 2021. The company was registered under the industry Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik. In 2020, the company reported a net result of DKK 0 compared with DKK 30 the year before. Equity in the 2020 report amounted to DKK 4,000.